Works matching IS 14642662 AND DT 2011 AND VI 12 AND IP 6

Results: 10

Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study)

Published in:

2011

By:

Podzamczer, D.;
Andrade-Villanueva, J.;
Clotet, B.;
Taylor, S.;
Rockstroh, J. K.;
Reiss, P.;
Domingo, P.;
Gellermann, H. J.;
de Rossi, L.;
Cairns, V.;
Soriano, V.

Publication type:

Journal Article

The effectiveness of pneumococcal polysaccharide vaccination in HIV-infected adults: a systematic review.

Published in:

HIV Medicine, 2011, v. 12, n. 6, p. 323, doi. 10.1111/j.1468-1293.2010.00892.x

By:

Pedersen, R. H.;
Lohse, N.;
Østergaard, L.;
Søgaard, O. S.

Publication type:

Article

Management of resistant mucocutaneous herpes simplex infections in AIDS patients: a clinical and virological challenge.

Published in:

HIV Medicine, 2011, v. 12, n. 6, p. 367, doi. 10.1111/j.1468-1293.2010.00896.x

By:

Barde, C.;
Piguet, V.;
Pechère, M.;
Masouye, I.;
Saurat, J.-H.;
Wunderli, W.;
Kaiser, L.;
Toutous Trellu, L.

Publication type:

Article

Paediatric European Network for Treatment of AIDS response to 2010 revision of World Health Organization recommendations on 'Antiretroviral therapy for HIV infection in infants and children'.

Published in:: HIV Medicine, 2011, v. 12, n. 6, p. 385, doi. 10.1111/j.1468-1293.2011.00914.x
Publication type:: Article

Travel for HIV care in England: a choice or a necessity?

Published in:

HIV Medicine, 2011, v. 12, n. 6, p. 361, doi. 10.1111/j.1468-1293.2010.00891.x

By:

Huntington, S.;
Chadborn, T.;
Rice, B. D.;
Brown, A. E.;
Delpech, V. C.

Publication type:

Article

US national estimation of emergency department utilization by patients given 'HIV/AIDS-related illness' as their primary diagnosis.

Published in:

HIV Medicine, 2011, v. 12, n. 6, p. 343, doi. 10.1111/j.1468-1293.2010.00888.x

By:

Shih, T.-Y.;
Chen, K.-F.;
Rothman, R. E.;
Hsieh, Y.-H.

Publication type:

Article

Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohort.

Published in:

HIV Medicine, 2011, v. 12, n. 6, p. 352, doi. 10.1111/j.1468-1293.2010.00890.x

By:

Cescon, A. M.;
Cooper, C.;
Chan, K.;
Palmer, A. K.;
Klein, M. B.;
Machouf, N.;
Loutfy, M. R.;
Raboud, J.;
Rachlis, A.;
Ding, E.;
Lima, V. D.;
Montaner, J. S. G.;
Rourke, S. B.;
Smieja, M.;
Tsoukas, C.;
Hogg, R. S.

Publication type:

Article

Antiviral activity of apricitabine in treatment-experienced HIV-1-infected patients with M184V who are failing combination therapy.

Published in:

HIV Medicine, 2011, v. 12, n. 6, p. 334, doi. 10.1111/j.1468-1293.2010.00887.x

By:

Cahn, P.;
Altclas, J.;
Martins, M.;
Losso, M.;
Cassetti, I.;
Cooper, D. A.;
Cox, S.

Publication type:

Article

Reduced delays in time to first HIV consultation after diagnosis in France in the antiretroviral therapy era: the possible role of a free care system.

Published in:

HIV Medicine, 2011, v. 12, n. 6, p. 383, doi. 10.1111/j.1468-1293.2010.00893.x

By:

Suzan-Monti, M.;
Fugon, L.;
Marcellin, F.;
Carrieri, M. P.;
Lert, F.;
Obadia, Y.;
Spire, B.

Publication type:

Article

Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study).

Published in:

HIV Medicine, 2011, v. 12, n. 6, p. 374, doi. 10.1111/j.1468-1293.2011.00917.x

By:

Podzamczer, D.;
Andrade-Villanueva, J.;
Clotet, B.;
Taylor, S.;
Rockstroh, J. K.;
Reiss, P.;
Domingo, P.;
Gellermann, H. J.;
de Rossi, L.;
Cairns, V.;
Soriano, V.

Publication type:

Article